Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Wall Street trims cancer drug developer BioNTech's unicorn valuation
Endpoints
Thu, 10/10/19 - 09:42 am
NASDAQ
IPOs
BioNTech
Oyster Point Pharma Files for $85 Million IPO
CP Wire
Mon, 10/7/19 - 10:57 am
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Oyster Point Pharma Files for $85 Million IPO
Mon, 10/7/19 - 10:09 am
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Xconomy
Thu, 10/3/19 - 10:08 pm
IPOs
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
ADC Therapeutics
Monopar Therapeutics
Cabaletta Bio Files for $100 Million IPO
CP Wire
Wed, 10/2/19 - 10:50 am
Cabaletta Bio
IPOs
autoimmune disease
DSG3-CAART
pemphigus vulgaris
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
CP Wire
Tue, 10/1/19 - 11:07 am
4D Molecular Therapeutics
IPOs
gene therapy
Gene-Editing Company Beam Seeks $100 Million IPO
BioSpace
Mon, 09/30/19 - 11:40 pm
Beam Therapeutics
IPOs
gene editing
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
Sat, 09/28/19 - 04:38 pm
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
Xconomy
Sat, 09/28/19 - 04:27 pm
Beam Therapeutics
IPOs
CRISPR
Does amount matter when it comes to a biotech IPO?
EP Vantage
Wed, 09/25/19 - 11:55 am
IPOs
biotech
NASDAQ
BioNTech
ADC Therapeutics
Frequency Therapeutics Updates $123 Million IPO Filing
CP Wire
Tue, 09/24/19 - 09:59 am
Frequency Therapeutics
IPOs
European biotech firm BioNtech plans to raise nearly $304 mln in U.S. IPO
Yahoo/Reuters
Tue, 09/24/19 - 09:38 am
Europe
IPOs
BioNTech
MRNA
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Endpoints
Mon, 09/23/19 - 10:49 am
Innate Pharma
IPOs
AstraZeneca
blood cancer
solid tumors
IPO take 2: Kindler's Centrexion restarts bid to fund pain trial
Fierce Biotech
Thu, 09/19/19 - 08:13 pm
Centrexion
IPOs
clinical trials
painkillers
CNTX-4975
osteoarthritis of the knee
3 Healthcare IPOs From 2018 That Have Already Doubled
Motley Fool
Wed, 09/18/19 - 09:49 am
IPOs
Guardant Health
Allakos
Twist Bioscience
IGM Updates its IPO - May Raise over $200 Million
CP Wire
Tue, 09/17/19 - 10:03 am
IGM Biosciences
IGM-2323
IPOs
IGM Updates its IPO - May Raise over $200 Million
Tue, 09/17/19 - 09:42 am
IGM Biosciences
IGM-2323
IPOs
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
Satsuma Pharmaceuticals Files for $80 Million IPO
CP Wire
Thu, 09/12/19 - 10:25 am
Satsuma Pharmaceuticals
STS101
migraine
IPOs
Satsuma Pharmaceuticals Files for $80 Million IPO
Thu, 09/12/19 - 09:33 am
Satsuma Pharmaceuticals
STS101
migraine
IPOs
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »